300 related articles for article (PubMed ID: 22929303)
1. Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models.
Ogura Y; Ouchi N; Ohashi K; Shibata R; Kataoka Y; Kambara T; Kito T; Maruyama S; Yuasa D; Matsuo K; Enomoto T; Uemura Y; Miyabe M; Ishii M; Yamamoto T; Shimizu Y; Walsh K; Murohara T
Circulation; 2012 Oct; 126(14):1728-38. PubMed ID: 22929303
[TBL] [Abstract][Full Text] [Related]
2. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart.
Oshima Y; Ouchi N; Sato K; Izumiya Y; Pimentel DR; Walsh K
Circulation; 2008 Jun; 117(24):3099-108. PubMed ID: 18519848
[TBL] [Abstract][Full Text] [Related]
3. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism.
Ouchi N; Oshima Y; Ohashi K; Higuchi A; Ikegami C; Izumiya Y; Walsh K
J Biol Chem; 2008 Nov; 283(47):32802-11. PubMed ID: 18718903
[TBL] [Abstract][Full Text] [Related]
4. Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.
Hayakawa S; Ohashi K; Shibata R; Kataoka Y; Miyabe M; Enomoto T; Joki Y; Shimizu Y; Kambara T; Uemura Y; Yuasa D; Ogawa H; Matsuo K; Hiramatsu-Ito M; van den Hoff MJ; Walsh K; Murohara T; Ouchi N
J Am Soc Nephrol; 2015 Mar; 26(3):636-46. PubMed ID: 25071081
[TBL] [Abstract][Full Text] [Related]
5. MiR-29a in mesenchymal stem cells inhibits FSTL1 secretion and promotes cardiac myocyte apoptosis in hypoxia-reoxygenation injury.
Li KS; Jiang WP; Li QC; Zhang HW; Bai Y; Zhang X; Li HY
Cardiovasc Pathol; 2020; 46():107180. PubMed ID: 31945680
[TBL] [Abstract][Full Text] [Related]
6. [Follistatin-like 1-engineered mesenchymal stem cells prevent myocardial ischemic reperfusion injury].
Zhang MQ; Chen H; Zhai CL; Tu JF; Shen Y; Pang LX; Xu QR
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2017-22. PubMed ID: 27470962
[TBL] [Abstract][Full Text] [Related]
7. Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury.
Miyabe M; Ohashi K; Shibata R; Uemura Y; Ogura Y; Yuasa D; Kambara T; Kataoka Y; Yamamoto T; Matsuo K; Joki Y; Enomoto T; Hayakawa S; Hiramatsu-Ito M; Ito M; Van Den Hoff MJ; Walsh K; Murohara T; Ouchi N
Cardiovasc Res; 2014 Jul; 103(1):111-20. PubMed ID: 24743592
[TBL] [Abstract][Full Text] [Related]
8. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
9. CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism.
Kambara T; Ohashi K; Shibata R; Ogura Y; Maruyama S; Enomoto T; Uemura Y; Shimizu Y; Yuasa D; Matsuo K; Miyabe M; Kataoka Y; Murohara T; Ouchi N
J Biol Chem; 2012 Jun; 287(23):18965-73. PubMed ID: 22514273
[TBL] [Abstract][Full Text] [Related]
10. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms.
Kataoka Y; Shibata R; Ohashi K; Kambara T; Enomoto T; Uemura Y; Ogura Y; Yuasa D; Matsuo K; Nagata T; Oba T; Yasukawa H; Numaguchi Y; Sone T; Murohara T; Ouchi N
J Am Coll Cardiol; 2014 Jun; 63(24):2722-33. PubMed ID: 24768874
[TBL] [Abstract][Full Text] [Related]
11. Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.
Maruyama S; Nakamura K; Papanicolaou KN; Sano S; Shimizu I; Asaumi Y; van den Hoff MJ; Ouchi N; Recchia FA; Walsh K
EMBO Mol Med; 2016 Aug; 8(8):949-66. PubMed ID: 27234440
[TBL] [Abstract][Full Text] [Related]
12. C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart.
Yuasa D; Ohashi K; Shibata R; Mizutani N; Kataoka Y; Kambara T; Uemura Y; Matsuo K; Kanemura N; Hayakawa S; Hiramatsu-Ito M; Ito M; Ogawa H; Murate T; Murohara T; Ouchi N
FASEB J; 2016 Mar; 30(3):1065-75. PubMed ID: 26578687
[TBL] [Abstract][Full Text] [Related]
13. Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury.
Otaka N; Shibata R; Ohashi K; Uemura Y; Kambara T; Enomoto T; Ogawa H; Ito M; Kawanishi H; Maruyama S; Joki Y; Fujikawa Y; Narita S; Unno K; Kawamoto Y; Murate T; Murohara T; Ouchi N
Circ Res; 2018 Dec; 123(12):1326-1338. PubMed ID: 30566056
[TBL] [Abstract][Full Text] [Related]
14. Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.
Seki M; Powers JC; Maruyama S; Zuriaga MA; Wu CL; Kurishima C; Kim L; Johnson J; Poidomani A; Wang T; Muñoz E; Rajan S; Park JY; Walsh K; Recchia FA
Circ Heart Fail; 2018 Jan; 11(1):e004486. PubMed ID: 29317401
[TBL] [Abstract][Full Text] [Related]
15. Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome.
Widera C; Giannitsis E; Kempf T; Korf-Klingebiel M; Fiedler B; Sharma S; Katus HA; Asaumi Y; Shimano M; Walsh K; Wollert KC
Clin Chem; 2012 Aug; 58(8):1233-41. PubMed ID: 22675198
[TBL] [Abstract][Full Text] [Related]
16. Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload.
Shimano M; Ouchi N; Nakamura K; van Wijk B; Ohashi K; Asaumi Y; Higuchi A; Pimentel DR; Sam F; Murohara T; van den Hoff MJ; Walsh K
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):E899-906. PubMed ID: 21987816
[TBL] [Abstract][Full Text] [Related]
17. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.
Oshima Y; Ouchi N; Shimano M; Pimentel DR; Papanicolaou KN; Panse KD; Tsuchida K; Lara-Pezzi E; Lee SJ; Walsh K
Circulation; 2009 Oct; 120(16):1606-15. PubMed ID: 19805648
[TBL] [Abstract][Full Text] [Related]
18. Follistatin-Like 1 Attenuates Ischemia/Reperfusion Injury in Cardiomyocytes via Regulation of Autophagy.
Yang W; Duan Q; Zhu X; Tao K; Dong A
Biomed Res Int; 2019; 2019():9537382. PubMed ID: 31139662
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.
Bao W; Hu E; Tao L; Boyce R; Mirabile R; Thudium DT; Ma XL; Willette RN; Yue TL
Cardiovasc Res; 2004 Feb; 61(3):548-58. PubMed ID: 14962485
[TBL] [Abstract][Full Text] [Related]
20. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
